Answers are grounded in this paper and cite their sources.
Introduction The incidence of pulmonary fungal infection (PFI) is increasing worldwide, particularly in critically ill patients. The aim was to assess, using bronchoscopic bronchoalveolar lavage (BAL), specimens for the diagnosis of clinically and radiologically suspected PFIs in critically ill children. Materials Thirty-five children, admitted to the Pediatric Intensive Care Unit because of their critical illness, were included. All children underwent full medical history evaluation and thorough clinical examination; basic laboratory investigations (from which the pediatric risk of mortality critical illness score was calculated) and chest imaging were carried out. Bronchoscopic BAL fluid and blood were cultured on Sabouraud Dextrose Agar. Fungal antigen-detection tests using the enzyme-linked immunosorbent assay, for both Aspergillus galactomannan antigen and Candida mannan antigen, were also carried out. Results PFI was defined as probable in 77% of the studied children. BAL investigations proved to have a higher diagnostic yield (P<0.001) compared with blood. Positive fungal antigens in BAL fluid were significantly higher than positive BAL fungal cultures in the studied children (P<0.001). Risk-factor analyses for fungal infection among the studied patients revealed that prolonged Pediatric Intensive Care Unit stay (≥1 wk) (odds ratio=24; 95% confidence interval: 2.14-650, P=0.002) and high pediatric risk of mortality (cutoff value 35; P<0.001) were significant risk factors for probable fungal infection. Conclusions BAL fluid sampling is a safe, technically simple procedure and has a significant diagnostic value for pediatric PFIs, especially if assessed with both fungal cultures and antigen fungal detections.
No takes yet. Share an insight, caveat, or question.
Kotby et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: